TKNO FY 2024 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena

TKNOAlpha Teknova, Inc.

$133M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$38M+2.9% YoY

Gross Profit

$7M19.2% margin

Operating Income

-$26M-69.3% margin

Net Income

-$27M-70.9% margin

EPS (Diluted)

$-0.57

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$14M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$119M

Total Liabilities

$36M

Stockholders' Equity

$82M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$37M	+2.9%
Gross Profit	$7M	$10M	-29.8%
Operating Income	-$26M	-$36M	+26.5%
Net Income	-$27M	-$37M	+27.3%